PREGNANCY AND DELIVERY IN WOMEN WITH A HISTORY OF PREECLAMPSIA HYPERHOMOCYSTEINEMIA TREATED WITH BEMIPARIN IN COMBINATION WITH LOW-DOSE ASPIRIN
https://doi.org/10.17749/2070-4968.2015.9.3.035-039
Abstract
Preeclampsia is a serious complication of pregnancy and one of the leading causes of maternal mortality. According to modern concepts, the key link in the pathogenesis of preeclampsia is an endothelial dysfunction leadind to persistent prothrombotic hemostasis state. Markers and predictors of preeclampsia considered hypercoagulation, hyperagregation and hyperhomocysteinemia. Women with the history of preterm labor and preeclampsia was treated by antithrombotic correction started on pregravid stage. Pregnancy successfully completed on time delivery without hypertensive complications.
About the Authors
L. O. Buzyan
South Ural State Medical University
Russian Federation
Russian Federation
G. G. Buzyan
South Ural State Medical University
Russian Federation
MD, Professor, Head of the Scientific Educational Center "Clinical Pharmacology"
Russian Federation
MD, Professor, Head of the Scientific Educational Center "Clinical Pharmacology"
V. F. Dolgushina
South Ural State Medical University
Russian Federation
MD, Professor, Head of the Department of Obstetrics and Gynecology
Russian Federation
MD, Professor, Head of the Department of Obstetrics and Gynecology
References
1. Clinical Protocol. Hypertension during pregnancy. Preeclampsia. Eclampsia: project "Mother and Child" [Klinicheskii protokol. Gipertenziya vo vremya beremennosti. Preeklampsiya. Eklampsiya: proekt «Mat' i Ditya» (in Russian)]. Moscow. 2012; 44.
2. Makatsariya A.D., Zhuravleva E.V., Andreeva M.D. Akusherstvo, ginekologiya i reproduktsiya. 2014; 4 (8): 74-75.
3. Reference data of the RF Ministry of Public Health [Spravochnye dannye Minzdravsotsrazvitiya RF (in Russian)]. Moscow. 2008.
4. Syundyukova E.G., Medvedev B.I., Sashenkov S.L. Vestnik YuzhnoUral'skogo gosudarstvennogo universiteta. Seriya: Obrazovanie, zdravookhranenie, fizicheskaya kul'tura. 2014; 1 (14): 88-93.
5. Duckitt K. et al. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005 Mar.; 12; 330: 565.
6. Laskowska M., Laskowska K., Terbosh M. et al. A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies. Med Sci Monit. 2013 Jun 5; 19: 430-7.
7. Pijnenborg R., Vercruysse L., Hanssens M. et al. Endovascular trophoblast and preeclampsia: A reassessment. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 2011 Jan; 1 (1): 66-71.
8. Visser S., Hermes W., Ket J.C. et al. Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders. Am J Obstet Gynecol. 2014 Oct; 211 (4): 373.e1-9.
9. Yao S., Wu H., Yu Y.H. Early intervention with aspirin for preventing preeclampsia in highrisk women: a meta-analysis. Nan Fang Yi Ke Da Xue Xue Bao. 2015 Jun 20; 35 (6): 868-73.
10.
Review
For citations:
Buzyan L.O., Buzyan G.G., Dolgushina V.F. PREGNANCY AND DELIVERY IN WOMEN WITH A HISTORY OF PREECLAMPSIA HYPERHOMOCYSTEINEMIA TREATED WITH BEMIPARIN IN COMBINATION WITH LOW-DOSE ASPIRIN. Obstetrics, Gynecology and Reproduction. 2015;9(3):35-39. (In Russ.) https://doi.org/10.17749/2070-4968.2015.9.3.035-039
Views:
683
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
